Showing results (1-10 of 113) with videos related to
Sort By:
Pageof 12
Current Drug Targets|June 23, 2007
Microarray-based identification of new targets for specific therapies in pediatric leukemiaMonique L den Boer, Rob PietersEuropean Journal of Cancer (Oxford, England : 1990)|July 15, 2017
BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedsideJudith M Boer, Monique L den BoerBritish Journal of Haematology|February 1, 2006
Towards targeted therapy for infant acute lymphoblastic leukaemiaRonald W Stam, Monique L den Boer, Rob PietersEJC Paediatric Oncology|March 23, 2026
From the bench of molecular understanding to the bedside of optimal therapy for <i>BCR</i>::<i>ABL1</i> and ABL-class acute lymphoblastic leukemia in children and adolescentsSarah K Tasian, Judith M Boer, Monique L den BoerSeminars in Hematology|December 23, 2008
New genetic abnormalities and treatment response in acute lymphoblastic leukemiaJules P P Meijerink, Monique L den Boer, Rob PietersBlood|August 23, 2015
B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironmentRoel Polak, Bob de Rooij, Rob Pieters, et al.Leukemia & Lymphoma|August 30, 2024
<i>IKZF1</i> in acute lymphoblastic leukemia: the rise before the fall?Anna Østergaard, Judith M Boer, Frank N van Leeuwen, et al.Blood|August 16, 2003
Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemiaAmy Holleman, Monique L den Boer, Karin M Kazemier, et al.Translational Oncology|June 22, 2020
Ibrutinib is not an effective drug in primografts of TCF3-PBX1Cesca van de Ven, Aurélie Boeree, Femke Stalpers, et al.Blood|June 7, 2013
STAT3 mediates oncogenic addiction to TEL-AML1 in t(12;21) acute lymphoblastic leukemiaMaurizio Mangolini, Jasper de Boer, Vanessa Walf-Vorderwülbecke, et al.Pageof 12